CEO Total Pay
$21.9M
FY2024 Summary Compensation, well above median
The CEO earned $21.9M in FY2024 against median worker pay of $79,510 · Chemicals & Pharmaceuticals.
Data updated August 2026
Subscribe to PROCTER & GAMBLE Co CEO pay filing updates (RSS)
Latest filing FY2024. This company's newest DEF 14A on file is for FY2024, not FY2025, so the figures on this page are from that earlier year and are not ranked against the FY2025 industry benchmark. Industry pages mark issuers like this one with a "Latest filing" label.
Answer first
Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.
Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.
A component-level pay breakdown is not reported in PROCTER & GAMBLE Co's structured SEC pay-ratio disclosure. See our methodology →
Complete DEF 14A pay-ratio filings for this CIK across FY2021–2024. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).
| FY | CEO pay | Δ pay | Median worker | Pay ratio | Δ ratio |
|---|---|---|---|---|---|
| 2021 | $18.0M | - | $65,918 | 273:1 | - |
| 2022 | $21.7M | +21% | $64,024 | 339:1 | +66:1 |
| 2023 | $23.0M | +5.7% | $69,934 | 329:1 | -10:1 |
| 2024 | $21.9M | -4.6% | $79,510 | 276:1 | -53:1 |
Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 80424, FY2021–2024. Adjacent-year deltas only.
PROCTER & GAMBLE Co disclosed 276:1 CEO-to-worker pay and $21.9M CEO total in FY2024. the CEO earned 276× the median employee ($79,510) in FY2024.
Median employee $79,510 (HIGH-MED); STEEP · PEAK stamps put about 276 median-wage years per CEO year.
CEO Total Pay
$21.9M
FY2024 Summary Compensation, well above median
Pay Ratio
276:1
Elevated vs. peers
PROCTER & GAMBLE Co disclosed 276:1 CEO-to-worker pay and $21.9M CEO total in FY2024. The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; PROCTER & GAMBLE Co's $21.9M CEO total is above the $7.9M industry median CEO pay.
PROCTER & GAMBLE Co stamps STEEP · PEAK · HIGH-MED; grant-date fair value (not realized pay) is what the DEF 14A reports. Open Chemicals & Pharmaceuticals peers.
Read our methodology - how this data is sourced, computed, and verified. PROCTER & GAMBLE Co disclosed 276:1 CEO-to-worker pay and $21.9M CEO total in FY2024.
ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps STEEP · PEAK · HIGH-MED.
ABS(ceo_total_comp) peer at $22.0M (Δ $41K heavier vs PROCTER & GAMBLE Co); STEEP · HIGH-MED vs this page's STEEP · PEAK · HIGH-MED.
ABS(ceo_total_comp) peer at $21.9M (Δ $58K lighter vs PROCTER & GAMBLE Co); EXTREME · PAR-MED vs this page's STEEP · PEAK · HIGH-MED.
ABS(ceo_total_comp) peer at $21.8M (Δ $69K lighter vs PROCTER & GAMBLE Co); STEEP · HIGH-MED vs this page's STEEP · PEAK · HIGH-MED.
ABS(ceo_total_comp) peer at $22.0M (Δ $70K heavier vs PROCTER & GAMBLE Co); STEEP · HIGH-MED vs this page's STEEP · PEAK · HIGH-MED.
PROCTER & GAMBLE Co stamps STEEP · PEAK · HIGH-MED inside SIC 28 - open the industry median board after the ABS peers.
See where STEEP · PEAK packages sit on the national leaderboard after reading PROCTER & GAMBLE Co.
PROCTER & GAMBLE Co's PEAK CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.